Sensus Healthcare Inc (SRTS) Stock Price, Quote & News

Company Profile

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as oth...

Industry: Medical Devices

Sector: Healthcare

Phone: 561 922 5808

Fax: 561 948 2071

Website: sensushealthcare.com

Address:

851 Broken Sound Parkway NW, Suite 215, Boca Raton, United States

Bravosatya May. 9 at 2:40 AM

$SRTS SkinCure Oncology and Sensus Healthcare have amicably resolved their prior dispute and are moving forward constructively with a shared commitment to patient care and clinical excellence.

0 · Reply

MarketBeat May. 9 at 2:06 AM

Sensus Healthcare Q1 Earnings Call Highlights $SRTS https://www.marketbeat.com/instant-alerts/sensus-healthcare-q1-earnings-call-highlights

0 · Reply

Arcides May. 8 at 9:29 PM

$SRTS a lot of baggies since this was 15 in 2022, medical devices is the worst group by far on markets...even worse than software.

0 · Reply

koditrump May. 8 at 1:07 PM

$SRTS

0 · Reply

StocktwitsEarnings May. 7 at 8:22 PM

$SRTS Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.16 • Reported revenue of $3.39M down -59.32% YoY

0 · Reply

SuperGreenToday Apr. 28 at 2:52 AM

$SRTS Share Price: $3.97 Contract Selected: Oct 16, 2026 $5 Calls Buy Zone: $0.26 – $0.32 Target Zone: $0.47 – $0.57 Potential Upside: 74% ROI Time to Expiration: 171 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Stradella Apr. 1 at 2:33 PM

$SRTS Up 12% today.... no news.... this is the most underfollowed stock.... UP 12% FOLKS!

0 · Reply

Bravosatya Mar. 27 at 1:03 PM

$SRTS how many of you believe in “Turnaround Story” of Sensus will gain Market share from Skincure- it’s clear now BATTLE is full ON . Who will win? Write your thoughts in comments !

1 · Reply

Bravosatya Mar. 27 at 12:55 PM

$SRTS read me thoughts on the Skincure lawsuit https://x.com/bravosatya/status/2037513400759022029?s=46&t=K-mrSWrpS0MBpymbXzaYcg

1 · Reply

DARKP00L Mar. 27 at 12:11 PM

$SRTS 08:10 on Mar. 27 2026 Sensus Healthcare Sues SkinCure Oncology Over Alleged Violation Of Contract Related To Unpaid Amounts Owed For Sensus Products #tradeideas

0 · Reply

Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology

2026-05-08T12:01:24.000Z - 5 days ago

Sensus Healthcare price target lowered to $6.50 from $7.50 at Alliance Global

2026-05-07T22:49:40.000Z - 6 days ago

Sensus Healthcare reports Q1 EPS (16c), consensus (11c)

May 7, 2026, 4:30 PM EDT - 6 days ago

Sensus Healthcare Earnings Call Transcript: Q1 2026

May 7, 2026, 4:05 PM EDT - 6 days ago

Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights

Apr 23, 2026, 5:56 PM EDT - 20 days ago

Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026

2026-03-27T12:06:12.000Z - 6 weeks ago

Sensus Healthcare files lawsuit against SkinCure for breach of contract

Mar 27, 2026, 8:00 AM EDT - 6 weeks ago

Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract

2026-03-06T12:05:32.000Z - 2 months ago

Sensus Healthcare initiated with a Buy at Alliance Global

Feb 26, 2026, 8:00 AM EST - 2 months ago

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base

Feb 18, 2026, 8:30 AM EST - 3 months ago

Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology

2026-02-17T14:01:03.000Z - 3 months ago

Sensus Healthcare price target lowered to $6 from $8 at Maxim

2026-02-12T21:36:23.000Z - 3 months ago

Sensus Healthcare reports Q4 EPS (19c) vs. 9c last year

Feb 12, 2026, 4:30 PM EST - 3 months ago

Sensus Healthcare Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:05 PM EST - 3 months ago

Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer

Feb 5, 2026, 8:00 AM EST - 3 months ago

Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026

Jan 7, 2026, 4:30 PM EST - 4 months ago

Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco

Jan 7, 2026, 8:30 AM EST - 4 months ago

Sensus Healthcare Appoints Larry Biscotti to its Board of Directors

2025-11-14T13:05:48.000Z - 6 months ago

Sensus Healthcare appoints Michael Sardano as chief commercial officer

Nov 14, 2025, 8:00 AM EST - 6 months ago

Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer

Nov 12, 2025, 8:00 AM EST - 6 months ago

Sensus Healthcare Appoints Eric Sachetta to its Board of Directors

2025-11-06T21:51:54.000Z - 6 months ago

Sensus Healthcare reports Q3 EPS (6c), consensus (11c)v

Nov 6, 2025, 4:30 PM EST - 6 months ago

Sensus Healthcare Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:05 PM EST - 6 months ago

Sensus Healthcare Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 8:00 AM EST - 6 months ago

Sensus Healthcare Named to TIME's America's Growth Leaders of 2026

2025-11-04T14:10:46.000Z - 6 months ago

Sensus Healthcare announces CMS treatment codes for superficial radiotherapy

Nov 4, 2025, 8:00 AM EST - 6 months ago

CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer

Oct 31, 2025, 8:00 AM EDT - 6 months ago

Sensus Healthcare Announces the Passing of Director Bill McCall

Oct 23, 2025, 8:00 AM EDT - 7 months ago

Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6

2025-09-23T12:11:17.000Z - 8 months ago

Sensus publishes data on superficial radiotherapy technology, punch excision

Sep 23, 2025, 8:00 AM EDT - 8 months ago

Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare's SRT Combined with Punch Excision to Treat Keloids

Aug 28, 2025, 3:43 PM EDT - 9 months ago

Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm

2025-08-12T10:20:25.000Z - 9 months ago

Sensus Healthcare price target lowered to $8 from $12 at H.C. Wainwright

2025-08-08T11:55:12.000Z - 9 months ago

Sensus Healthcare price target lowered to $6 from $13 at Lake Street

2025-08-07T20:54:38.000Z - 9 months ago

Sensus Healthcare reports Q2 EPS (6c), consensus 1c

Aug 7, 2025, 4:30 PM EDT - 9 months ago

Sensus Healthcare Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 9 months ago

Sensus Healthcare Reports Second Quarter 2025 Financial Results

Jul 24, 2025, 4:15 PM EDT - 10 months ago

Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7

2025-07-24T12:16:00.000Z - 10 months ago

Sensus Healthcare superficial radiation therapy systems get MDSAP certification

Jul 24, 2025, 8:00 AM EDT - 10 months ago

Receipt of MDSAP Certification for Sensus Healthcare's Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts

2025-06-26T12:06:25.000Z - 11 months ago

Sensus Healthcare enters strategic agreement with Radiology Oncology Systems

Jun 26, 2025, 8:00 AM EDT - 11 months ago

Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists

2025-05-19T12:50:31.000Z - 1 year ago

Sensus Healthcare price target lowered to $10 from $14 at Maxim

May 15, 2025, 4:30 PM EDT - 1 year ago

Sensus Healthcare Earnings Call Transcript: Q1 2025

2025-05-15T20:15:22.000Z - 1 year ago

Sensus Healthcare reports Q1 EPS (16c), consensus 2c

May 15, 2025, 4:05 PM EDT - 1 year ago

Sensus Healthcare Reports First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 1 year ago

Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments

May 1, 2025, 8:00 AM EDT - 1 year ago

Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15

Mar 13, 2025, 8:00 AM EDT - 1 year ago

Sensus Healthcare to Participate in the 37th Annual ROTH Conference

2025-03-11T12:51:31.000Z - 1 year ago

Sensus Healthcare price target lowered to $13 from $18 at Lake Street

Mar 6, 2025, 8:00 AM EST - 1 year ago

Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting

Mar 4, 2025, 8:00 AM EST - 1 year ago

Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence

2025-02-27T20:05:17.000Z - 1 year ago

Sensus Healthcare participates in a conference call with Lake Street

2025-02-11T13:12:20.000Z - 1 year ago

Sensus resumed purchasing of stock under $3M share repurchase program

Feb 11, 2025, 8:00 AM EST - 1 year ago

Sensus Healthcare Buys Back Shares

Feb 5, 2025, 4:30 PM EST - 1 year ago

Sensus Healthcare Earnings Call Transcript: Q4 2024

Feb 5, 2025, 4:05 PM EST - 1 year ago

Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 23, 2025, 8:00 AM EST - 1 year ago

Sensus Healthcare to Present at The Microcap Conference 2025

Jan 22, 2025, 8:00 AM EST - 1 year ago

Sensus Healthcare to Report 2024 Fourth Quarter and Full Year Financial Results and Hold Business Update Conference Call on Wednesday, February 5, 2025

Dec 4, 2024, 8:30 AM EST - 1 year ago

Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration

Nov 17, 2024, 8:32 PM EST - 1 year ago

REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Nov 14, 2024, 4:30 PM EST - 1 year ago

Sensus Healthcare Earnings Call Transcript: Q3 2024

Nov 14, 2024, 12:06 PM EST - 1 year ago

Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Sensus Healthcare Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Sensus Healthcare Reports Second Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Second Quarter

Jul 25, 2024, 4:05 PM EDT - 1 year ago

Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Sensus Healthcare Earnings Call Transcript: Q1 2024

May 9, 2024, 4:05 PM EDT - 2 years ago

Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold

May 9, 2024, 8:30 AM EDT - 2 years ago

Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare's SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats

Apr 18, 2024, 4:05 PM EDT - 2 years ago

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024

Mar 14, 2024, 4:05 PM EDT - 2 years ago

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

Feb 8, 2024, 4:30 PM EST - 2 years ago

Sensus Healthcare Earnings Call Transcript: Q4 2023

Feb 8, 2024, 4:05 PM EST - 2 years ago

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

Bravosatya May. 9 at 2:40 AM

$SRTS SkinCure Oncology and Sensus Healthcare have amicably resolved their prior dispute and are moving forward constructively with a shared commitment to patient care and clinical excellence.

0 · Reply

MarketBeat May. 9 at 2:06 AM

Sensus Healthcare Q1 Earnings Call Highlights $SRTS https://www.marketbeat.com/instant-alerts/sensus-healthcare-q1-earnings-call-highlights

0 · Reply

Arcides May. 8 at 9:29 PM

$SRTS a lot of baggies since this was 15 in 2022, medical devices is the worst group by far on markets...even worse than software.

0 · Reply

koditrump May. 8 at 1:07 PM

$SRTS

0 · Reply

StocktwitsEarnings May. 7 at 8:22 PM

$SRTS Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.16 • Reported revenue of $3.39M down -59.32% YoY

0 · Reply

SuperGreenToday Apr. 28 at 2:52 AM

0 · Reply

Stradella Apr. 1 at 2:33 PM

$SRTS Up 12% today.... no news.... this is the most underfollowed stock.... UP 12% FOLKS!

0 · Reply

Bravosatya Mar. 27 at 1:03 PM

$SRTS how many of you believe in “Turnaround Story” of Sensus will gain Market share from Skincure- it’s clear now BATTLE is full ON . Who will win? Write your thoughts in comments !

1 · Reply

Bravosatya Mar. 27 at 12:55 PM

$SRTS read me thoughts on the Skincure lawsuit https://x.com/bravosatya/status/2037513400759022029?s=46&t=K-mrSWrpS0MBpymbXzaYcg

1 · Reply

DARKP00L Mar. 27 at 12:11 PM

$SRTS 08:10 on Mar. 27 2026 Sensus Healthcare Sues SkinCure Oncology Over Alleged Violation Of Contract Related To Unpaid Amounts Owed For Sensus Products #tradeideas

0 · Reply

koditrump Mar. 24 at 1:40 PM

$SRTS $ON $TXN $TSLA $PLTR

0 · Reply

Bravosatya Mar. 24 at 12:26 PM

$SRTS check out my impact analysis of the Skincure FDA clearance news on Sensus business on X - https://x.com/bravosatya/status/2036419116731380206?s=46&t=K-mrSWrpS0MBpymbXzaYcg

0 · Reply

Bravosatya Mar. 23 at 10:55 PM

$SRTS long waited competition is now FDA cleared. https://www.prnewswire.com/news-releases/skincure-oncology-introduces-fda-cleared-gentlebeam-expanding-image-guided-capabilities-in-dermatology-practices-302722335.html

0 · Reply

OfficialStocktwitsUser Mar. 23 at 8:59 PM

$SRTS RSI: 34.18, MACD: -0.1222 Vol: 0.24, MA20: 4.12, MA50: 4.50 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

koditrump Mar. 10 at 3:32 PM

$VERI $POET $EL $SRTS $TSLA

0 · Reply

Bravosatya Mar. 7 at 10:11 PM

$SRTS this Skincure Law Suit will help $SRTS https://www.prnewswire.com/news-releases/skincure-oncology-seeks-federal-court-injunction-to-cease-unlawful-effort-to-strip-medicare-coverage-for-image-guided-superficial-radiation-therapy-302707183.html

1 · Reply

Stradella Mar. 7 at 2:13 AM

$SRTS Alliance Global analyst Scott Henry initiated coverage of Sensus Healthcare (SRTS) with a Buy rating and $7.50 price target. Sensus sells the SRT-100/Vision medical device to deliver superficial radiation therapy for the treatment of oncological and non-oncological skin conditions, notes the analyst, who expects strong revenue growth for the SRT platform, particularly with new reimbursement codes in place for 2026. https://www.tipranks.com/news/the-fly/sensus-healthcare-initiated-with-a-buy-at-alliance-global-thefly-news

0 · Reply

koditrump Mar. 6 at 2:53 PM

$UAMY $SRTS $FANG $TSLA

0 · Reply

Bravosatya Mar. 4 at 8:01 PM

$SRTS Update- As of December 31, 2025, Sensus had installed 955 units across 21 countries. Sec 10K Submission- http://sec.gov/Archives/edgar…

0 · Reply

Stradella Mar. 3 at 9:42 PM

$SRTS Wow, closed green in another ugly day for stocks.

0 · Reply

koditrump Mar. 3 at 8:43 PM

$PLTR $POET $SRTS $TSLA $UAMY Stop fretting!! Blessed to be here in the US😁 No Bombs

0 · Reply

OfficialStocktwitsUser Mar. 3 at 8:07 PM

$SRTS RSI: 43.96, MACD: -0.1077 Vol: 0.50, MA20: 4.38, MA50: 4.48 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Market Cap	56.14M
Revenue (ttm)	27.48M
Net Income (ttm)	-7.72M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-28.09%
Debt to Equity Ratio	0.00

Volume	41,200
Avg Vol	62,230
Day's Range	N/A - N/A
Shares Out	16.46M
Stochastic %K	38%
Beta	1.19
Analysts	Strong Sell
Price Target	$6.62